BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7872381)

  • 1. The empiric use of gonadotropin therapy and intrauterine insemination.
    Schlaff W; Yazigi R; Olive DL; Williams DB; Steinkampf M; Odem RR
    Am J Obstet Gynecol; 1995 Feb; 172(2 Pt 2):778-82. PubMed ID: 7872381
    [No Abstract]   [Full Text] [Related]  

  • 2. Ovulation induction in the ovulatory woman.
    Silverberg KM
    Semin Reprod Endocrinol; 1996 Nov; 14(4):339-44. PubMed ID: 8988528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting live birth outcomes after in vitro fertilisation.
    Nelson SM; Lawlor DA
    BJOG; 2012 Dec; 119(13):1668; author reply 1668-9. PubMed ID: 23164114
    [No Abstract]   [Full Text] [Related]  

  • 4. Superovulation and intrauterine insemination vs. superovulation alone in the treatment of unexplained infertility. A randomized study.
    Arcaini L; Bianchi S; Baglioni A; Marchini M; Tozzi L; Fedele L
    J Reprod Med; 1996 Aug; 41(8):614-8. PubMed ID: 8866392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between endometrial thickness and pregnancy outcome in gonadotropin-stimulated intrauterine insemination cycles.
    Liu Y; Ye XY; Chan C
    Reprod Biol Endocrinol; 2019 Jan; 17(1):14. PubMed ID: 30674305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of high vaginal insemination at oocyte recovery in patients undergoing in vitro fertilization.
    Fishel S; Webster J; Jackson P; Faratian B
    Fertil Steril; 1989 Jan; 51(1):135-8. PubMed ID: 2910708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medically assisted procreation. Main biological, medical and ethical aspects ].
    Roux C; Berdin A; Amiot C
    Rev Prat; 2014 Dec; 64(10):1435-44. PubMed ID: 25665331
    [No Abstract]   [Full Text] [Related]  

  • 8. Do younger women with elevated basal follicular stimulating hormone levels undergoing gonadotropin-stimulated intrauterine insemination cycles represent compromised reproductive outcomes?
    Devranoğlu B; Özdamar Ö; Köle E; Eken MK; Bozdağ H; Doğer E
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():141-5. PubMed ID: 26930042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heterologous artificial insemination in patients with disordered ovulatory processes].
    Davydov SN; Kustarov VN; Kol'tsov MI
    Akush Ginekol (Mosk); 1987 Sep; (9):20-2. PubMed ID: 3425831
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjunctive agents in ovulation induction.
    Ginsburg KA; Yeko TR; Heiner JS; Gast MJ
    Am J Obstet Gynecol; 1995 Feb; 172(2 Pt 2):782-5. PubMed ID: 7872382
    [No Abstract]   [Full Text] [Related]  

  • 11. Should couples with unexplained infertility have three to six cycles of intrauterine insemination with ovarian stimulation or in vitro fertilization as first-line treatment?
    Ombelet W; van Eekelen R; McNally A; Ledger W; Doody K; Farquhar C
    Fertil Steril; 2020 Dec; 114(6):1141-1148. PubMed ID: 33280720
    [No Abstract]   [Full Text] [Related]  

  • 12. Sextuplet pregnancy after human menopausal gonadotropin superovulation and intrauterine insemination. A case report.
    Friedman AJ
    J Reprod Med; 1990 Feb; 35(2):113-5. PubMed ID: 2106029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovulation induction in the poor responder or hyperresponder.
    O'Shea DL; Kettel M; Isaacs JD; Olive DL; Radwanska E; Odem RR
    Am J Obstet Gynecol; 1995 Feb; 172(2 Pt 2):788-91. PubMed ID: 7872384
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recommendations of good practice: medicines that induce ovulation (June 2003)].
    AFSSAPS
    Gynecol Obstet Fertil; 2003; 31(7-8):676-86. PubMed ID: 14563614
    [No Abstract]   [Full Text] [Related]  

  • 15. Endometriosis-associated infertility: aspects of pathophysiological mechanisms and treatment options.
    Tanbo T; Fedorcsak P
    Acta Obstet Gynecol Scand; 2017 Jun; 96(6):659-667. PubMed ID: 27998009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cetrorelix lowers premature luteinization rate in gonadotropin ovulation induction-intrauterine insemination cycles: a randomized-controlled clinical trial.
    Steward RG; Gill I; Williams DB; Witz CA; Griffith J; Haddad GF
    Fertil Steril; 2011 Jan; 95(1):434-6. PubMed ID: 20810107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-adherence to instructions to cancel a cycle in a patient overstimulated with gonadotropins in a planned intrauterine insemination cycle.
    Awonuga AO; Schenone MH; Abdallah ME; Yelian FD; Diamond MP; Puscheck EE
    J Clin Ethics; 2009; 20(3):235-8. PubMed ID: 19845194
    [No Abstract]   [Full Text] [Related]  

  • 18. Luteal phase support after mild ovulation induction with intrauterine insemination: an on-going debate.
    Aytac PC; Bulgan Kilicdag E; Haydardedeoglu B; Simsek E; Cok T; Coban G
    Gynecol Endocrinol; 2016 Jul; 32(7):543-7. PubMed ID: 26850073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian stimulation in infertile women treated with the use of intrauterine insemination: a cohort study from China.
    Huang S; Wang R; Li R; Wang H; Qiao J; Mol BWJ
    Fertil Steril; 2018 May; 109(5):872-878. PubMed ID: 29778386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New perspectives for unexplained infertility.
    Hatasaka H
    Clin Obstet Gynecol; 2011 Dec; 54(4):727-33. PubMed ID: 22031262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.